id: Q9HCC8
gene_symbol: GDPD2
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: GDPD2 (Glycerophosphoinositol inositolphosphodiesterase GDPD2) is a membrane-bound
  enzyme that specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol
  and inositol 1-phosphate. It functions as an ecto-enzyme with its catalytic domain
  oriented extracellularly, requiring millimolar Ca2+ as a cofactor. GDPD2 plays a
  critical role in promoting osteoblast differentiation and serves as a marker of
  osteoblast maturation. The protein localizes to the plasma membrane as a multi-pass
  membrane protein and colocalizes with actin filaments, suggesting involvement in
  cytoskeletal remodeling during cell differentiation.
existing_annotations:
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Plasma membrane localization is well-supported by experimental evidence.
      GDPD2 is a multi-pass membrane protein with transmembrane segments that anchor
      it in the membrane, with its catalytic domain oriented extracellularly. UniProt
      and literature confirm this membrane localization is essential for its ecto-enzyme
      function.
    action: ACCEPT
    reason: Strong experimental evidence from biochemical and cell biology studies
      confirms GDPD2 as a plasma membrane protein with multiple transmembrane passes.
      The extracellular orientation of the catalytic domain and requirement for membrane
      anchoring to process extracellular glycerophosphoinositol support this core
      cellular component annotation.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 is a multi-pass membrane protein predominantly localized
        at the plasma membrane. Topology studies indicate that it spans the membrane
        multiple times, anchoring the protein at the cell surface.
- term:
    id: GO:0008889
    label: glycerophosphodiester phosphodiesterase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: This term is correct but less specific than the actual enzymatic activity.
      GDPD2 has been experimentally characterized as having glycerophosphoinositol
      inositolphosphodiesterase activity (GO:0047394), which is a more specific child
      term that precisely describes its substrate specificity for glycerophosphoinositol.
    action: MODIFY
    reason: While GDPD2 does possess glycerophosphodiester phosphodiesterase activity,
      experimental evidence demonstrates it specifically acts on glycerophosphoinositol
      and not on other glycerophosphodiesters like glycerophosphocholine or glycerophosphoethanolamine.
      The more specific term GO:0047394 better captures this substrate specificity.
    proposed_replacement_terms:
    - id: GO:0047394
      label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: This enzyme specifically hydrolyzes glycerophosphoinositol
        (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act
        on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate,
        glycerophosphocholine, -ethanolamine, or -serine
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: This annotation is misleading as GDPD2 is primarily a plasma membrane
      protein with its catalytic domain oriented extracellularly. While there may
      be some cytoplasmic association via its transmembrane segments or interaction
      with cytoskeletal elements, the primary and functionally relevant localization
      is the plasma membrane, not the cytoplasm.
    action: REMOVE
    reason: GDPD2 is a multi-pass transmembrane protein with its functional catalytic
      domain on the extracellular side of the plasma membrane. The cytoplasm annotation
      likely comes from automatic mapping but does not reflect the actual topology
      and functional localization of the protein. The plasma membrane annotation already
      captures the correct localization.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: The catalytic domain resides on the extracellular side of the
        membrane, consistent with the finding that glycerophosphoinositol is hydrolyzed
        in the extracellular medium by overexpressed GDPD2
- term:
    id: GO:0005856
    label: cytoskeleton
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: While GDPD2 colocalizes with actin filaments and may associate with the
      cytoskeleton, the more specific term GO:0005884 (actin filament) better captures
      this interaction. The broad cytoskeleton term is too general.
    action: MODIFY
    reason: Evidence indicates GDPD2 specifically colocalizes with actin filaments
      rather than the cytoskeleton in general. The protein appears to concentrate
      at sites of actin-rich membrane structures and influences cell morphology, suggesting
      a specific association with the actin cytoskeleton rather than other cytoskeletal
      components.
    proposed_replacement_terms:
    - id: GO:0005884
      label: actin filament
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 has been observed in the cytoplasm associated with the
        cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2
        may concentrate at sites of actin-rich membrane structures
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This plasma membrane annotation is correct and consistent with experimental
      evidence. This IEA annotation independently supports the IBA annotation for
      the same term, confirming plasma membrane localization through different computational
      methods.
    action: ACCEPT
    reason: Multiple lines of evidence including transmembrane domain predictions,
      experimental topology studies, and functional characterization all confirm GDPD2
      as a plasma membrane protein. This annotation correctly captures a core cellular
      component for this protein.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 is a multi-pass membrane protein predominantly localized
        at the plasma membrane
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: This broad term is correct but vague. GDPD2 specifically catalyzes the
      hydrolysis of glycerophosphoinositol, a glycerophospholipid metabolite. More
      specific terms like glycerophospholipid metabolic process (GO:0006650) or phospholipid
      catabolic process would be more informative.
    action: MODIFY
    reason: While GDPD2 is involved in lipid metabolism, its specific function is
      the catabolism of glycerophosphoinositol, a glycerophospholipid derivative.
      A more specific biological process term would better represent its actual metabolic
      role.
    proposed_replacement_terms:
    - id: GO:0006650
      label: glycerophospholipid metabolic process
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2s unique lipid substrate specificity ties it to lipid
        metabolic processes, particularly the catabolism of glycerophosphoinositol
        lipids
- term:
    id: GO:0008081
    label: phosphoric diester hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: This is a correct parent term for GDPD2s enzymatic activity, but too
      general. The more specific glycerophosphoinositol inositolphosphodiesterase
      activity (GO:0047394) should be used as it precisely describes the substrate
      specificity.
    action: MODIFY
    reason: GDPD2 does have phosphoric diester hydrolase activity, but experimental
      characterization has shown it specifically acts on glycerophosphoinositol. Using
      the more specific molecular function term provides better functional annotation.
    proposed_replacement_terms:
    - id: GO:0047394
      label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 encodes an enzyme with glycerophosphoinositol inositolphosphodiesterase
        activity (EC 3.1.4.43)
- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This extremely broad term is correct but uninformative. GDPD2 has been
      experimentally characterized with specific glycerophosphoinositol inositolphosphodiesterase
      activity, which should be the primary molecular function annotation.
    action: MARK_AS_OVER_ANNOTATED
    reason: While technically correct that GDPD2 is a hydrolase, this term is too
      general to be useful. The specific enzymatic activity (glycerophosphoinositol
      inositolphosphodiesterase) has been experimentally determined and should be
      the focus of molecular function annotations.
    proposed_replacement_terms:
    - id: GO:0047394
      label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: This enzyme specifically hydrolyzes glycerophosphoinositol
        (GroPIns) into glycerol and inositol 1-phosphate
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: This annotation is correct but could be more specific. GDPD2 specifically
      requires Ca2+ as a cofactor for its enzymatic activity. The more specific term
      calcium ion binding (GO:0005509) would be more informative.
    action: MODIFY
    reason: Experimental evidence shows GDPD2 specifically requires millimolar Ca2+
      as a cofactor for its catalytic activity. The calcium ion binding annotation
      would more precisely represent this metal ion requirement.
    proposed_replacement_terms:
    - id: GO:0005509
      label: calcium ion binding
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+
        as a cofactor
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: The active site of the GP-PDE domain requires divalent cations
        for catalysis â€“ notably Ca2+ acts as a cofactor to facilitate bond cleavage
- term:
    id: GO:0047394
    label: glycerophosphoinositol inositolphosphodiesterase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: This annotation precisely captures the experimentally determined enzymatic
      activity of GDPD2. Multiple studies have confirmed that GDPD2 specifically hydrolyzes
      glycerophosphoinositol to produce glycerol and inositol 1-phosphate, with no
      activity on other glycerophosphodiesters.
    action: ACCEPT
    reason: This is the most specific and accurate molecular function annotation for
      GDPD2. Experimental evidence clearly demonstrates this specific enzymatic activity
      (EC 3.1.4.43) with strict substrate specificity for glycerophosphoinositol.
      This represents the core molecular function of the protein.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: This enzyme specifically hydrolyzes glycerophosphoinositol
        (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act
        on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate,
        glycerophosphocholine, -ethanolamine, or -serine
- term:
    id: GO:0005884
    label: actin filament
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: GDPD2 colocalizes with actin filaments according to literature and database
      annotations. This association may be related to its role in cell morphology
      changes during osteoblast differentiation, though this represents a secondary
      localization compared to its primary plasma membrane residence.
    action: KEEP_AS_NON_CORE
    reason: While GDPD2 does colocalize with actin filaments, this is not its primary
      localization or core function. The protein is primarily a plasma membrane ecto-enzyme,
      and the actin association may be relevant for its effects on cell morphology
      during differentiation but is not essential for its enzymatic function.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: In addition to the cell surface, GDPD2 has been observed in
        the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: This suggests that GDPD2 may concentrate at sites of actin-rich
        membrane structures (e.g. ruffles or protrusions), potentially linking its
        enzymatic activity to cytoskeletal remodeling
- term:
    id: GO:0007015
    label: actin filament organization
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: There is some evidence that GDPD2 influences cell morphology and cytoskeletal
      arrangement, particularly during osteoblast differentiation. However, this appears
      to be an indirect effect of its enzymatic activity rather than a direct role
      in actin organization.
    action: KEEP_AS_NON_CORE
    reason: Changes in cell morphology were observed upon altering GDPD2 levels, suggesting
      involvement in cytoskeletal remodeling. However, this is likely a downstream
      effect of its lipid metabolic activity and role in differentiation rather than
      a direct function in actin organization. This represents a peripheral rather
      than core function.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 has been associated with actin cytoskeleton organization,
        as changes in cell morphology and cytoskeletal arrangement were observed upon
        altering GDPD2 levels
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: experiments noted GDPD2s influence on cell shape and morphology,
        supporting a role at the interface of the plasma membrane and the actin cytoskeleton
- term:
    id: GO:0030027
    label: lamellipodium
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: There is no strong experimental evidence specifically placing GDPD2 in
      lamellipodia. While GDPD2 colocalizes with actin and may be at membrane ruffles,
      specific lamellipodium localization has not been demonstrated experimentally.
    action: REMOVE
    reason: This annotation appears to be an over-interpretation based on actin colocalization.
      While GDPD2 may be present at actin-rich membrane structures, there is no direct
      evidence for specific lamellipodium localization. The plasma membrane and actin
      filament annotations already capture the relevant cellular localizations.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: This suggests that GDPD2 may concentrate at sites of actin-rich
        membrane structures (e.g. ruffles or protrusions)
- term:
    id: GO:0045669
    label: positive regulation of osteoblast differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: This annotation is strongly supported by experimental evidence. GDPD2
      is upregulated during osteoblast maturation and overexpression promotes osteoblast
      differentiation with increased alkaline phosphatase activity and mineralization.
      This represents a core biological function of GDPD2.
    action: ACCEPT
    reason: Multiple experimental studies demonstrate that GDPD2 promotes osteoblast
      differentiation. It is considered a marker of osteoblast maturation, and overexpression
      accelerates the osteogenic program. This is one of the best-characterized biological
      roles of GDPD2 and represents a core function.
    supported_by:
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: Overexpression of GDPD2 (GDE3) in osteoblastic cells has been
        shown to promote osteoblast differentiation, evidenced by increased alkaline
        phosphatase activity and mineralized calcium deposition
    - reference_id: file:human/GDPD2/GDPD2-deep-research.md
      supporting_text: GDPD2 accelerates the program of osteoblast differentiation
        and growth
core_functions:
- description: Glycerophosphoinositol-specific phosphodiesterase activity with calcium-dependent
    catalysis at the plasma membrane
  molecular_function:
    id: GO:0047394
    label: glycerophosphoinositol inositolphosphodiesterase activity
  supported_by:
  - reference_id: file:human/GDPD2/GDPD2-deep-research.md
    supporting_text: This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns)
      into glycerol and inositol 1-phosphate, and notably does not act on related
      glycerophosphodiesters
  directly_involved_in:
  - id: GO:0006650
    label: glycerophospholipid metabolic process
  - id: GO:0045669
    label: positive regulation of osteoblast differentiation
  locations:
  - id: GO:0005886
    label: plasma membrane
- description: Calcium ion binding required for enzymatic activity
  molecular_function:
    id: GO:0005509
    label: calcium ion binding
  supported_by:
  - reference_id: file:human/GDPD2/GDPD2-deep-research.md
    supporting_text: GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+
      as a cofactor
  directly_involved_in:
  - id: GO:0006650
    label: glycerophospholipid metabolic process
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: file:human/GDPD2/GDPD2-deep-research.md
  title: Deep Research Report on GDPD2
  findings:
  - statement: GDPD2 colocalizes with actin filaments and may influence cytoskeletal
      remodeling
    supporting_text: GDPD2 has been observed in the cytoplasm associated with the
      cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2 may
      concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions),
      potentially linking its enzymatic activity to cytoskeletal remodeling
    reference_section_type: OTHER
suggested_questions:
- question: What is the physiological concentration of extracellular glycerophosphoinositol
    in bone tissue and how does it change during osteoblast differentiation?
  experts:
  - bone_biology
  - lipid_metabolism
- question: Does GDPD2 have any additional substrates beyond glycerophosphoinositol
    under specific cellular conditions?
  experts:
  - enzymology
  - biochemistry
- question: What are the downstream signaling effects of the inositol 1-phosphate
    product generated by GDPD2 activity?
  experts:
  - cell_signaling
  - phosphoinositide_biology
- question: Is GDPD2 activity regulated by post-translational modifications or protein-protein
    interactions during osteoblast differentiation?
  experts:
  - protein_biochemistry
  - bone_biology
- question: What is the functional significance of GDPD2 colocalization with actin
    filaments at the plasma membrane?
  experts:
  - cell_biology
  - cytoskeleton
suggested_experiments:
- description: GDPD2 knockout mouse model to assess skeletal phenotype
  experiment_type: GENETIC_MANIPULATION
  hypothesis: Loss of GDPD2 will result in decreased bone density and impaired osteoblast
    differentiation in vivo
- description: Live-cell imaging of fluorescently-tagged GDPD2 during osteoblast differentiation
  experiment_type: CELL_BIOLOGY
  hypothesis: GDPD2 localization and dynamics change during the transition from proliferating
    to differentiating osteoblasts
- description: Mass spectrometry-based lipidomics to measure glycerophosphoinositol
    levels in GDPD2-overexpressing vs control cells
  experiment_type: BIOCHEMISTRY
  hypothesis: GDPD2 overexpression will deplete extracellular glycerophosphoinositol
    pools and alter downstream lipid metabolites
- description: Co-immunoprecipitation and proximity labeling to identify GDPD2 protein
    interaction partners
  experiment_type: PROTEOMICS
  hypothesis: GDPD2 forms complexes with cytoskeletal proteins or other membrane-associated
    signaling molecules
- description: Structure determination of GDPD2 catalytic domain by X-ray crystallography
    or cryo-EM
  experiment_type: STRUCTURAL_BIOLOGY
  hypothesis: Structural analysis will reveal the molecular basis for substrate specificity
    and calcium dependence
status: COMPLETE
